KAKKAR RAHUL enters PANDION THERAPEUTICS, INC. with 681.38K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 7/16/2020ACC: 0000899243-20-019459
DirectorOfficer· Chief Executive Officer
Since Jul 2020
681.38K
Baseline shares
0.00
Direct ownership
0 positions
21.13K
Derivative underlying
1 instrument
1
Security positions
681.38K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned681.38K
Total
681.38K indirect681.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 681.38K | Indirect |
| Total | 681.38K | 681.38K indirect |
Derivative Holdings1
Series B Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
21.13K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
21.13K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock | — | — | 21.13K | N/A | |
| Total | 21.13K | 0.00 | ||||